JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 7 February 2005. doi:10.1083/jcb.200411060
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 168, Number 4, 561-566
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1588K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J. Y.
Right arrow Articles by Khavari, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J. Y.
Right arrow Articles by Khavari, P. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Report

CDK4 regulation by TNFR1 and JNK is required for NF-{kappa}B–mediated epidermal growth control



Jennifer Y. Zhang1,2, Shiying Tao1,2, Robin Kimmel1,2, and Paul A. Khavari1,2

1 Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA 94304
2 Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA 94305

Correspondence to Paul A. Khavari: khavari{at}CMGM.stanford.edu


Abstract

Nuclear factor {kappa}B (NF-{kappa}B) mediates homeostatic growth inhibition in the epidermis, and a loss of NF-{kappa}B function promotes proliferation and oncogenesis. To identify mechanisms responsible for these effects, we impaired NF-{kappa}B action in the epidermis by three different genetic approaches, including conditional NF-{kappa}B blockade. In each case, epidermal hyperplasia was accompanied by an increase in both protein levels and tissue distribution of the G1 cell cycle kinase, CDK4. CDK4 up-regulation required intact TNFR1 and c-Jun NH2-terminal kinase (JNK) function. Cdk4 gene deletion concomitant with conditional NF-{kappa}B blockade demonstrated that CDK4 is required for growth deregulation. Therefore, epidermal homeostasis depends on antagonist regulation of CDK4 expression by NF-{kappa}B and TNFR1/JNK.

Abbreviations used in this paper: 4OHT, 4-hydoxytamoxifen; BMZ, basement membrane zone; ER, estrogen receptor; I{kappa}B, inhibitor of {kappa}B; JNK, c-Jun NH2-terminal kinase; NF-{kappa}B, nuclear factor {kappa}B.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents